Skip To The Main Content

The following educational activity will augment education of the BHS Medical Staff to the new guidelines for anticoagulant usage and provide an update of new drugs available.

Upon completion of this activity the participant will be able to:

  • Discuss appropriate usage of new direct thrombin inhibitors and factor Xa inhibitors.
  • Assess the impact of these drugs on traditional laboratory tests for coagulation monitoring.
  • Apply treatment recommendations for emergency bleeding in patients on these medications.

This activity was created by Emily Volk, M.D., Medical Director, Dept of Laboratory Medicine and Pathology and Paige Cuellar, Pharm D, Regional Clinical Care Coordinator, Baptist Health System

The speakers and planners have no financial relationships to disclose that would affect the content of this activity.

Release date – 5/1/2014 Expiration date – 4/30/2015

CME Credit

It is anticipated this activity will take approximately 1 hour to complete the activity and post-test. The Activity consists of a video after which there is a link to the post-test. Upon completion of the activity and an 80% score on the post-test you will receive 1 AMA PRA Category 1 Credit(s).

You must be a member of the Baptist Health System Medical Staff and have a valid BHS Physician ID number to receive CME Credit. Your CME Credit will be recorded and tracked by the BHS CME Department. You may contact the CME Department at or (210) 297-8632 to get a copy of your CME transcript. You can only received CME Credit once in a 12-month period for this activity.

The Baptist Health System designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s). Physicians should claim credit commensurate with the extent of their participation in the activity.

The Baptist Health System is accredited by the Texas Medical Association to provide continuing medical education for physicians.

Target Specific Oral Anticoagulants Video